-
KOSPI 2577.27 -2.21 -0.09%
-
KOSDAQ 722.52 -7.07 -0.97%
-
KOSPI200 341.49 +0.02 +0.01%
-
USD/KRW 1396 -2.00 0.14%
Abpro
Search results
-
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
